Management of Hyponatremia in Heart Failure
Introduction to Hyponatremia Management
- The American College of Cardiology recommends that patients with hypervolemic dilutional hyponatremia, such as those with heart failure, should have their diuretic therapy intensified with intravenous loop diuretics in combination with the addition of a second diuretic, while avoiding strict fluid restriction in the first 24 hours of treatment, and consider the use of tolvaptan for correction of hyponatremia 1.
Diuretic Therapy
- The American Heart Association suggests starting with intravenous furosemide at a dose equal to or exceeding the chronic oral daily dose, and titrating the dose based on diuresis and clinical signs of congestion 3, 4.
- If diuresis is insufficient, adding a second diuretic with a complementary mechanism of action, such as metolazone, intravenous chlorothiazide, or spironolactone, is recommended 3, 4, 5.
Fluid Management
- The American College of Cardiology advises against strict fluid restriction in the first 24 hours of active diuretic therapy to avoid too rapid correction of sodium and worsening of hypotension 7, 8.
- After the first 24 hours, fluid intake should be limited to approximately 2 liters per day for most patients with heart failure, with more stringent restriction for refractory hyponatremia 7, 8.
Management of Hypotension
- The European Society of Cardiology recommends that if there are clinical signs of hypotension with hypoperfusion and evident signs of increased filling pressure, intravenous inotropic agents, such as dobutamine, or vasopressors should be administered to maintain systemic perfusion 3, 4.
Continuation of Baseline Heart Failure Therapy
- The American College of Cardiology suggests continuing ACE inhibitors (or ARBs) and beta-blockers in stable patients without hemodynamic instability, with cautious application in elderly patients due to altered pharmacokinetics and risk of hypotension 3, 9.